Avalo Therapeutics (AVTX) FCF Margin Growth (3y) (2019 - 2025)
Avalo Therapeutics (AVTX) FCF Margin Growth (3y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Avalo Therapeutics |
295.77 Mn |
295.77 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-2.38 Mn |
| Dec 31, 2024 |
-2,263.00 |
| Sep 30, 2024 |
-341,665.00 |
| Dec 31, 2023 |
47,584.00 |
| Sep 30, 2023 |
-182,253.00 |
| Jun 30, 2023 |
-107,539.00 |
| Mar 31, 2023 |
-194,109.00 |
| Dec 31, 2022 |
-13,981.00 |
| Sep 30, 2022 |
38,422.00 |
| Jun 30, 2022 |
-72,347.00 |
| Mar 31, 2022 |
-124,213.00 |
| Dec 31, 2021 |
-785,198.00 |
| Sep 30, 2021 |
-119,849.00 |
| Jun 30, 2021 |
-56,478.00 |
| Mar 31, 2021 |
-387,006.00 |
| Dec 31, 2020 |
-82,606.00 |
| Sep 30, 2020 |
-115,043.00 |
| Jun 30, 2020 |
47,535.00 |
| Mar 31, 2020 |
37,418.00 |
| Dec 31, 2019 |
175,584.00 |
